Dartmouth, Canada

Genevieve Mary Weir

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Dartmouth, CA (2016 - 2021)
  • Halifax, CA (2018 - 2022)
  • Medford, MA (US) (2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Genevieve Mary Weir: Innovator in Vaccine Composition

Introduction

Genevieve Mary Weir, based in Dartmouth, CA, is a prominent inventor with a remarkable portfolio of 12 patents. Her work primarily focuses on innovative compositions and methods related to vaccine development, harnessing advanced techniques to enhance immune responses against diseases.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance." This invention provides a novel composition that includes an antigen, liposomes, a poly(I:C) polynucleotide, and a carrier that consists of a continuous phase of a hydrophobic substance, offering new methods for creating and utilizing these compositions. Another significant patent is related to "Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof." This application focuses on vaccine formulations that contain an amphipathic compound and a neoantigen, detailing methods to elicit significant antibody immune responses, with implications for cancer treatment.

Career Highlights

Genevieve is associated with Immunovaccine Technologies Inc., a leading company in the field of therapeutic vaccine development. Her role at the company has been instrumental in advancing research and developing patentable inventions that contribute significantly to the medical field.

Collaborations

Throughout her career, Genevieve has collaborated with notable colleagues Marc Mansour and Leeladhar Sammatur. These collaborations have fostered an environment of innovation and have led to the successful development of her patented inventions.

Conclusion

Genevieve Mary Weir's contributions to vaccine composition through her innovative patents underscore her essential role in the medical research community. Her work not only advances scientific understanding but also holds the potential to significantly impact public health through improved vaccine strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…